Artificial intelligence in predicting EGFR mutations from whole slide images in lung Cancer: A systematic review and Meta-Analysis.

Journal: Lung cancer (Amsterdam, Netherlands)
Published Date:

Abstract

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations play a pivotal role in guiding targeted therapy for lung cancer, making their accurate detection essential for personalized treatment. Recently, artificial intelligence (AI) has emerged as a promising tool for identifying EGFR mutation status from digital pathology images. This systematic review and meta-analysis evaluate the diagnostic accuracy of AI models in predicting EGFR mutations from whole slide images (WSIs) in lung cancer patients.

Authors

  • Mai Hanh Nguyen
    International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Pathology and Forensic Medicine Department, 103 Military Hospital, Hanoi, Vietnam; AIBioMed Research Group, Taipei Medical University, Taipei 110, Taiwan.
  • Minh Huu Nhat Le
    International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; AIBioMed Research Group, Taipei Medical University, Taipei 110, Taiwan.
  • Anh Tuan Bui
    Department of Spine Surgery, 103 Military Hospital, Hanoi, Vietnam.
  • Nguyen Quoc Khanh Le
    In-Service Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; AIBioMed Research Group, Taipei Medical University, Taipei 110, Taiwan; Translational Imaging Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan. Electronic address: khanhlee@tmu.edu.tw.